Catalyzing Healthcare Breakthroughs: Inventiva’s AI-Driven Biopharmaceutical Revolution
Inventiva, a biopharmaceutical company listed on Euronext Paris, has been at the forefront of AI-driven drug discovery and development, with a primary focus on oral small molecule therapies. In this article, we delve into Inventiva’s AI-related endeavors, drug candidates, and strategic collaborations. Inventiva’s Core Mission Inventiva’s overarching mission revolves around the development of cutting-edge therapeutics…